Results 21 to 30 of about 5,227,561 (214)
MicroRNAs and Polycystic Kidney Disease
Kidney Medicine, 2020 Important advances have been made regarding the diagnosis and management of polycystic kidney diseases. Care of patients with polycystic kidney diseases has moved beyond supportive care for complications and chronic kidney disease to new potentially ...
Dantong Li, Liangzhong Sun
doaj +1 more source
, 2023 Objective: The autosomal dominant polycystic kidney disease is the most common genetic cause of chronic kidney disease. In this context, it was aimed to investigate the demographical, clinical, and laboratory findings of, and the treatment methods ...
SEYAHİ, NURHAN +9 more
core +1 more source
Combined liver-kidney transplant in polycystic diseases: a case report [PDF]
Einstein (São Paulo), 2023 Polycystic liver disease, a hereditary pathology, usually manifests as autosomal dominant polycystic kidney disease. The many cysts in the liver cause massive hepatomegaly, majorly affecting the patient’s quality of life. In cases of refractory symptoms,
Olival Cirilo Lucena da Fonseca Neto +7 more
doaj +1 more source
Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy. [PDF]
PLoS ONE, 2015 Autosomal recessive polycystic kidney disease is a truly catastrophic monogenetic disease, causing death and end stage renal disease in neonates and children.
K J Kelly +6 more
doaj +1 more source
Molecular Mechanisms of Isolated Polycystic Liver Diseases
Frontiers in Genetics, 2022 Polycystic liver disease (PLD) is a rare autosomal dominant disorder including two genetically and clinically distinct forms: autosomal dominant polycystic kidney disease (ADPKD) and isolated polycystic liver disease (PCLD).
Ziqi Yu +5 more
doaj +1 more source
Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a polycystin-2 (TRPP2)-dependent manner. [PDF]
, 2013 Identifying and characterising potential new therapeutic agents to target cell proliferation may provide improved treatments for neoplastic disorders such as cancer and polycystic ...
Baines, D +20 more
core +1 more source
Inverting the patient involvement paradigm: defining patient led research
Research Involvement and Engagement, 2018 Plain English Summary Patients usually understand their disease and lifestyle needs better than many medical professionals. They also have important ideas about what research would be most beneficial to their lives, especially on how to manage symptoms ...
Laura B. Mader +4 more
doaj +1 more source
Surgical Management of Autosomal Dominant Polycystic Kidney Disease: Principles and Current Practice
Journal of Nepal Medical Association, 2023 Autosomal dominant polycystic kidney disease is the third most common cause of renal failure with no definitive treatment available that can directly target the development and growth of the cysts.
Badri Man Shrestha
doaj +1 more source
Emphysematous polycystic infection in a patient on peritoneal dialysis
Saudi Journal of Kidney Diseases and Transplantation, 2014 Emphysematous infection of the cysts in patients with polycystic kidney disease is very rare and seldom reported. We herein report a case of emphysematous polycystic infection in a 61-year-old male patient who was on peritoneal dialysis for end-stage ...
Shankar Prasad Nagaraju +3 more
doaj +1 more source
MicroRNAs and Polycystic Kidney Disease
, 2015 MicroRNAs (miRNAs) are a class of small non protein-coding RNAs that function as inhibitors of post-transcriptional gene expression in plants and animals. Over a thousand different miRNAs are known to be encoded by the human genome, the majority of which
core +1 more source